ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,859.90
0.10%
S&P ASX All Technology
3,073.60
-0.14%
Brent Oil
82.175
-0.33%
US Dollar vs AUD
1.50038
0.03%
Bitcoin
69,483.83
-0.92%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ciphergen Biosystems (MM) (CIPH)

  7. Ciphergen Biosystems (MM) (CIPH) News

CIPH

Ciphergen Biosystems (CIPH)

Ciphergen Biosystems (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CIPH
DateTimeSourceHeadlineSymbolCompany
27/08/200721:00PR Newswire (US)Vermillion Completes Name Change From Ciphergen BiosystemsNASDAQ:CIPHCiphergen Biosystems (MM)
24/08/200722:43PR Newswire (US)Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common StockNASDAQ:CIPHCiphergen Biosystems (MM)
18/08/200706:05PR Newswire (US)Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock MarketNASDAQ:CIPHCiphergen Biosystems (MM)
14/08/200706:05PR Newswire (US)Ciphergen Reports Second Quarter 2007 Financial Results and Business ProgressNASDAQ:CIPHCiphergen Biosystems (MM)
11/07/200723:00PR Newswire (US)Ciphergen Biosystems Receives Notice of Intent from U.S. Patent Office for Re-Issuance of SELDI Mass Spectrometry PatentNASDAQ:CIPHCiphergen Biosystems (MM)
11/07/200702:10PR Newswire (US)Ciphergen Biosystems Licenses More Than 25 Patents From Health Discovery CorporationNASDAQ:CIPHCiphergen Biosystems (MM)
07/07/200700:00PR Newswire (US)Ciphergen Biosystems Announces Results of Annual MeetingNASDAQ:CIPHCiphergen Biosystems (MM)
31/05/200700:00PR Newswire (US)Ciphergen Biosystems Announces Issuance of European Patent Covering a Method for Aiding Bladder Cancer DiagnosisNASDAQ:CIPHCiphergen Biosystems (MM)
17/05/200700:00PR Newswire (US)Ciphergen Reports First Quarter 2007 Financial Results and Business ProgressNASDAQ:CIPHCiphergen Biosystems (MM)
16/05/200707:47PR Newswire (US)Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and MarketingNASDAQ:CIPHCiphergen Biosystems (MM)
15/05/200700:30PR Newswire (US)Ciphergen to Announce Q1 2007 Financial Results and Host Conference Call on Wednesday, May 16, 2007NASDAQ:CIPHCiphergen Biosystems (MM)
09/05/200707:30PR Newswire (US)Ciphergen to Webcast Presentation at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference, MonacoNASDAQ:CIPHCiphergen Biosystems (MM)
17/04/200700:00PR Newswire (US)Ciphergen Biosystems Discovers Protein Biomarkers Useful for Diagnosis of Early-Stage Ovarian CancerNASDAQ:CIPHCiphergen Biosystems (MM)
12/04/200700:00PR Newswire (US)Ciphergen Biosystems Announces Presentation at Upcoming American Association for Cancer Research Annual MeetingNASDAQ:CIPHCiphergen Biosystems (MM)
10/04/200707:04PR Newswire (US)Ciphergen Biosystems' Auditors Expressed Going-Concern QualificationNASDAQ:CIPHCiphergen Biosystems (MM)
29/03/200704:00Business WireDutton Associates Announces Investment Opinion: Ciphergen Biosystems Initial Rating At Speculative Buy By Dutton AssociatesNASDAQ:CIPHCiphergen Biosystems (MM)
06/03/200701:00PR Newswire (US)Ciphergen Presents Data Validating Ovarian Cancer Triage Test at Society of Gynecologic Oncologists Annual MeetingNASDAQ:CIPHCiphergen Biosystems (MM)
24/02/200700:00PR Newswire (US)Ciphergen Reports Fourth Quarter and Year-End 2006 Financial Results and Provides Milestones For 2007NASDAQ:CIPHCiphergen Biosystems (MM)
21/02/200701:00PR Newswire (US)Ciphergen to Announce Fourth Quarter and Year End 2006 Financial Results and Host Conference Call on Friday, February 23, 2007NASDAQ:CIPHCiphergen Biosystems (MM)
14/02/200701:08PR Newswire (US)Ciphergen Initiates Clinical Trial for Ovarian Cancer Triage TestNASDAQ:CIPHCiphergen Biosystems (MM)
10/02/200701:00PR Newswire (US)Ciphergen to Participate at the BIO CEO and Investor ConferenceNASDAQ:CIPHCiphergen Biosystems (MM)
10/02/200701:00PR Newswire (US)Ciphergen to Participate at the BIO CEO and Investor ConferenceNASDAQ:CIPHCiphergen Biosystems (MM)
30/01/200701:00PR Newswire (US)Ciphergen Announces Publication of Data Describing Application for Evaluating Patients with Blood DisorderNASDAQ:CIPHCiphergen Biosystems (MM)
26/01/200701:00PR Newswire (US)Ciphergen Announces Issuance of European Patent Covering a Method for Aiding Prostate Cancer DiagnosisNASDAQ:CIPHCiphergen Biosystems (MM)
04/01/200701:00PR Newswire (US)Ciphergen Announces Second Development Program With Quest DiagnosticsNASDAQ:CIPHCiphergen Biosystems (MM)
22/12/200601:00PR Newswire (US)Ciphergen Chooses Mosaic to Develop Broad Reimbursement Strategy for Ovarian Tumor Triage TestNASDAQ:CIPHCiphergen Biosystems (MM)
20/12/200601:00PR Newswire (US)Ciphergen Selects Emergo Group, Inc. as Authorized Representative in EuropeNASDAQ:CIPHCiphergen Biosystems (MM)
16/12/200601:00PR Newswire (US)Ciphergen Engages PrecisionMed, Inc. as Clinical Trial CRO for Ovarian Tumor Triage Test Clinical TrialsNASDAQ:CIPHCiphergen Biosystems (MM)
12/12/200601:00PR Newswire (US)Ciphergen Announces Presentation of Data Demonstrating Use of Diagnostic Test to Monitor Blood DisorderNASDAQ:CIPHCiphergen Biosystems (MM)
29/11/200601:00PR Newswire (US)Ciphergen and Ohio State University Research Foundation Sign Collaborative Agreement to Develop Diagnostic Test for Blood DisordNASDAQ:CIPHCiphergen Biosystems (MM)
 Showing the most relevant articles for your search:NASDAQ:CIPH

Your Recent History

FX
EURAUD
Euro vs AUD
FX
AUDCAD
AUD vs CAD
ASX
XFL
S&P ASX 50
NYSE
JPM
JP Morgan Chase
ASX
XMM
S&P ASX 300 Metals and M...
ASX
QBE
QBE Insurance
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
NASDAQ
GOOGL
Alphabet
NASDAQ
AMZN
Amazon.com
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
XTO
S&P ASX 100
ASX
ORG
Origin Energy
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved